Delivery Order 36F79721D0141-36C24526N0565
Award Date 5/4/26
Potential Completion Date 5/8/26
Potential Value $41K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $43,266.00 delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Recordati Rare Diseases Inc. to provide SIGNIFOR LAR 30 MG AND 40 MG pharmaceuticals. The contract is issued against Recordati's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is a firm fixed price delivery order with a completion date of April 16, 2024. No set-aside designation was used. Recordati Rare Diseases Inc. is a foreign-owned, for-profit...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor, Recordati Rare Diseases Inc. Division, will deliver the pharmaceutical to the VA Veterans Integrated Service Network 5 location in Bartlett, Tennessee between December 7-11, 2023. The firm fixed price order is funded by the VA-VHA to support its provision of...
- Recordati Rare Diseases Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor LAR 30 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The potential value of this firm fixed price order is $21,623.35 to be performed at a place of performance in Bartlett, Tennessee by January 31, 2024. Recordati holds two key indefinite-delivery vehicles for supplying...
- <p>Veterans Integrated Service Network 5 issued a $27,448.04 delivery order to Recordati Rare Diseases Inc. on June 25, 2026, for Signifor 40 mg LAR under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB).</p> <p>Signifor LAR (pasireotide) is a specialized orphan pharmaceutical treatment for Cushing's disease and acromegaly. Place of performance is Bartlett, TN. The order is firm fixed-price with an ultimate completion date of June 30, 2026. No set-aside was used.</p>
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,793.52 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract to supply SIGNIFOR LAR 30 MG. The prime contractor, Recordati Rare Diseases Inc., will deliver the specified pharmaceutical to the VA facility located in Bartlett, Tennessee. The order has a period of performance from December 27, 2023 through December 29, 2023 and utilizes a firm fixed price contract type....
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $22,438.42, is for the supply of Signifor LAR 40 mg, an orphan drug used to treat rare medical conditions. The contract was awarded under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, and has an ultimate completion date of April 8, 2025. The...
- The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Recordati Rare Diseases Inc., a division of the Recordati Group, for the pharmaceutical product Signifor LAR 40 mg. The contract has a ceiling value of $10,811.24 and an ultimate completion date of November 22, 2024. This delivery order is placed against Recordati's five-year, $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, which allows for the procurement of the company's...
- The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group, for the provision of Signifor LAR 40 mg. The order, valued at $10,811.24, is being delivered under Recordati's Federal Supply Schedule (FSS-61-IB) contract with the VA, a five-year, $15.6 million indefinite-delivery vehicle established in April 2021. The contract does not include a set-aside designation, reflecting...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $22,438.42 contract is for the drug SIGNIFOR LAR 40 MG and is part of the company's broader Federal Supply Schedule (FSS-61-IB) contract with the VA, valued at $15.6 million, as well as a $3,156,115 Blanket Purchase Agreement covering multiple rare disease treatments. The award has no set-aside...
- The Department of Veterans Affairs Veterans Health Administration awarded a $21,746.58 delivery order against Recordati Rare Diseases Inc.'s GSA Schedule contract for the pharmaceutical products SIGNIFOR LAR 20 & 40 MG. The prime contractor Recordati Rare Diseases Inc. will provide the drugs to VA facilities located in Bartlett, Tennessee over a two day period from December 12-14, 2023. The contract was awarded under Recordati's Pharmaceuticals and Drugs GSA Schedule, a multiple award IDIQ...